Cabometyx 20 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FDK92
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,633
Award facts
- Contract value 100% obligated
- $16,632.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,632.54 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 30 tablets of Cabometyx 20 mg on August 6, 2025, with a completion date of August 7, 2025. This delivery order was issued without a set-aside designation and represents a direct pharmaceutical supply to support Department of Defense healthcare operations. Cabometyx (cabozantinib) is an oncology medication used in cancer treatment, reflecting DMS Pharmaceutical Group's established role as a critical supplier of specialized pharmaceutical products to military health facilities.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, executes this delivery order under a larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026. The company has demonstrated consistent success in federal pharmaceutical procurement, leveraging its woman-owned small business status to compete effectively while maintaining a robust portfolio of prescription medications, biologics, and medical consumables. This delivery order exemplifies the operational execution of DMS Pharmaceutical Group's strategic partnership with the Defense Logistics Agency to ensure pharmaceutical supply continuity across the military healthcare system.
Quick answers
Who was awarded contract SPE2DB25FDK92?
SPE2DB25FDK92 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FDK92 worth?
The government has obligated $16,633 on SPE2DB25FDK92.
Is contract SPE2DB25FDK92 an order under another contract?
Yes. SPE2DB25FDK92 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDK92 competed?
The extent of competition for SPE2DB25FDK92 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award